Osaic Holdings
UTHR icon

Osaic Holdings’s United Therapeutics UTHR Stock Holding History

Osaic Holdings’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.61M Buy
11,041
+289
+3% +$149K 0.01% 1454
2026
Q2 		$5.83M Buy
10,752
+6,223
+137% +$3.5M 0.01% 1423
2026
Q1 		$2.69M Sell
4,529
-6,469
-59% -$3.22M ﹤0.01% 1830
2025
Q4 		$5.36M Sell
10,998
-37,385
-77% -$17.4M 0.01% 1326
2025
Q3 		$20.1M Buy
48,383
+2,301
+5% +$774K 0.03% 615
2025
Q2 		$14M Buy
46,082
+33,662
+271% +$10.1M 0.03% 654
2025
Q1 		$3.83M Sell
12,420
-3,310
-21% -$1.13M 0.01% 1204
2024
Q4 		$4.55M Buy
15,730
+1,294
+9% +$476K 0.01% 1086
2024
Q3 		$5.17M Buy
14,436
+2,105
+17% +$711K 0.01% 1018
2024
Q2 		$3.93M Sell
12,331
-1,254
-9% -$332K 0.01% 1158
2024
Q1 		$3.12M Sell
13,585
-18,774
-58% -$4.24M 0.01% 1374
2023
Q4 		$7.12M Sell
32,359
-1,915
-6% -$441K 0.01% 975
2023
Q3 		$7.74M Buy
34,274
+24,054
+235% +$5.54M 0.01% 1005
2023
Q2 		$2.26M Sell
10,220
-89
-0.9% -$19.7K ﹤0.01% 1757
2023
Q1 		$2.31M Sell
10,309
-4,303
-29% -$1.06M ﹤0.01% 1709
2022
Q4 		$4.06M Buy
14,612
+8,887
+155% +$2.24M 0.01% 1243
2022
Q3 		$1.2M Buy
5,725
+463
+9% +$104K ﹤0.01% 2050
2022
Q2 		$1.24M Sell
5,262
-230
-4% -$46.8K ﹤0.01% 2072
2022
Q1 		$1.3M Sell
5,492
-498
-8% -$94.9K ﹤0.01% 2330
2021
Q4 		$1.29M Buy
5,990
+2,731
+84% +$536K ﹤0.01% 2151
2021
Q3 		$603K Buy
3,259
+208
+7% +$41K ﹤0.01% 2850
2021
Q2 		$548K Buy
3,051
+161
+6% +$30.7K ﹤0.01% 2931
2021
Q1 		$487K Buy
2,890
+290
+11% +$48.4K ﹤0.01% 2891
2020
Q4 		$396K Sell
2,600
-50
-2% -$6.56K ﹤0.01% 2861
2020
Q3 		$274K Buy
2,650
+143
+6% +$15.7K ﹤0.01% 2968
2020
Q2 		$303K Buy
2,507
+1,388
+124% +$156K ﹤0.01% 2771
2020
Q1 		$108K Buy
+1,119
New +$106K ﹤0.01% 3413

Other funds holding UTHR

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Osaic Holdings's UTHR Position: Q3 2026 in Review

Osaic Holdings increased its United Therapeutics (UTHR) stake by 2.7% in Q3 2026, buying an estimated $149K and bringing the position to 11,041 shares worth $5.61M. The position accounts for 0.01% of the portfolio, ranked #1454.

Osaic Holdings first reported a position in UTHR in Q1 2020 and has held it in 27 quarters since. The position peaked at $20.1M in Q3 2025. 673 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Osaic Holdings held 11,041 shares of United Therapeutics worth $5.61M as of Q3 2026.
  • Osaic Holdings bought 289 United Therapeutics shares in Q3 2026, an estimated $149K.
  • United Therapeutics made up 0.01% of Osaic Holdings's portfolio in Q3 2026, its #1454 holding.
  • Osaic Holdings first reported a position in United Therapeutics in Q1 2020 and has held it in 27 quarters since.
  • Osaic Holdings's United Therapeutics position peaked at $20.1M in Q3 2025.
  • 673 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.